Market Research Report
Report Package - 4 for 2: "Drug the Undruggable" Technologies
|Published by||La Merie Publishing||Product code||936691|
|Published||Content info||4 Reports
Delivery time: 1-2 business days
|Report Package - 4 for 2: "Drug the Undruggable" Technologies|
|Published: May 18, 2020||Content info: 4 Reports||
This report package includes four full reports for the price of two:
This report provides you with a landscape description and analysis of Targeted Protein Degradation (TPD) technologies and of discovery and development of TPD drug candidates from an industry perspective as of May 2020. This report evaluates the industry landscape of targeted protein degradation with novel PROTAC and molecular glue technologies and compounds. The report is based on the identification and description of 20 major biopharmaceutical and 24 technology-focused companies with targeted protein degradation technologies and research and development activities.
This report provides you with a landscape description and analysis of discovery and development of small molecules against RNA as a drug target from an industry perspective as of September 2019.
This report brings you up-to-date regarding key technologies
This report published in May 2018 brings you up-to-date regarding key TCR-T players, key TCR-T technologies and product candidates, business models, deals and funding opportunities. The report analyzes the TCR-T pipelines and stakeholders in the field, especially focused and diversified TCR-T companies and their relationship with academia and major pharma/biotech. The report highlights the value of TCR-T assets in terms of partnering economic conditions, acquisition prices and financing rounds.